|
|
| J-280S / JADO Tech (0 Trials) |
|
| J147 / Abrexa (0 Trials) |
|
| J2H-1701 / J2HBiotech (0 Trials) |
|
| J2H-1702 / J2HBiotech (0 Trials) |
|
| J2H-1801 / J2HBiotech (0 Trials) |
|
| J2H-1802 / J2HBiotech (0 Trials) |
|
| J2H-1803 / J2HBiotech (0 Trials) |
|
| J2H-1908 / J2HBiotech (0 Trials) |
|
| J2H-2002 / J2HBiotech (0 Trials) |
|
| J2H-P1904 / J2HBiotech (0 Trials) |
|
| J2H-P1905 / J2HBiotech (0 Trials) |
|
| J391B / JADO Tech (0 Trials) |
|
| J582C / JADO Tech (0 Trials) |
|
| J607Y / JADO Tech (0 Trials) |
|
| J775Y / JADO Tech (0 Trials) |
|
| JAB-22000 / Jacobio Pharma (0 Trials) |
|
| JAB-23000 / Jacobio Pharma (0 Trials) |
|
| JAB-23400 / Jacobio Pharma (0 Trials) |
|
| JAB-24114 / Jacobio Pharma (0 Trials) |
|
| JAB-2485 / Jacobio Pharma (0 Trials) |
|
| JAB-26766 / Jacobio Pharma (0 Trials) |
|
| JAB-30000 / Jacobio Pharma (0 Trials) |
|
| JAB-30300 / Jacobio Pharma (0 Trials) |
|
| JAB-3068 / Jacobio Pharma (0 Trials) |
|
| JAB-6343 / Jacobio Pharma (0 Trials) |
|
| JAB-8263 / Jacobio Pharma (0 Trials) |
|
| JAB-BX100 / Jacobio Pharma (0 Trials) |
|
| JAB-BX102 / Jacobio Pharma (0 Trials) |
|
| JAB-BX200 / Jacobio Pharma (0 Trials) |
|
| JAB-BX300 / Jacobio Pharma (0 Trials) |
|
| JAB-BX400 / Jacobio Pharma (0 Trials) |
|
| JAB-X1800 / Jacobio Pharma (0 Trials) |
|
| JACI-35.054 / AC Immune, J&J (0 Trials) |
|
| Jade / Cullinan Oncology (0 Trials) |
|
| JadiCell (allogeneic umbilical cord mesenchymal stem cells) / Therapeutic Solutions (0 Trials) |
|
| JAK2 inhibitor / Eli Lilly (0 Trials) |
|
| JAK3 kinase inhibitors / Novartis, Gilead (0 Trials) |
|
| Jakafi (ruxolitinib) / Incyte (213 Trials) |
|
| jaktinib / Suzhou Zelgen (0 Trials) |
|
| jaktinib hydrochloride cream / Suzhou Zelgen (0 Trials) |
|
| Janacti (sitagliptin/pioglitazone) / Merck (MSD) (0 Trials) |
|
| janagliflozin / Sihuan Pharmaceutical (0 Trials) |
|
| janthinobacterium lividum (DBI-001) / DermBiont (0 Trials) |
|
| Janumet (metformin/sitagliptin) / Merck (MSD) (1 Trials) |
|
| Janumet XR (sitagliptin/metformin extended-release) / Merck (MSD) (0 Trials) |
|
| Januvia (sitagliptin) / Merck (MSD) (59 Trials) |
|
| JANX007 / Janux Therapeutics (0 Trials) |
|
| JANX008 / Janux Therapeutics (0 Trials) |
|
| JANX009 / Janux Therapeutics (0 Trials) |
|
| Japanese Encephalitis vaccine / Panacea Biotec (0 Trials) |
|
| Jaqbo (zastaprazan) / Jeil (0 Trials) |
|
| Jardiance (empagliflozin) / Eli Lilly, Boehringer Ingelheim (207 Trials) |
|
| Jatenzo (testosterone undecanoate) / Tolmar (0 Trials) |
|
| Javlor (vinflunine) / Pierre Fabre (5 Trials) |
|
| Jaypirca (pirtobrutinib) / Eli Lilly (0 Trials) |
|
| JB6121 / Roche, Janus Biotherap (0 Trials) |
|
| JBH492 / Novartis (0 Trials) |
|
| JBI-1044 / Jubilant Pharmova (0 Trials) |
|
| JBI-2174 / Jubilant Pharmova (0 Trials) |
|
| JBI-426 / Jubilant Pharmova (0 Trials) |
|
| JBI-778 / Jubilant Pharmova (0 Trials) |
|
| JBI-802 / Jubilant Pharmova (0 Trials) |
|
| JBI128 / Jubilant Pharmova (0 Trials) |
|
| JBI295 / Jubilant Pharmova (0 Trials) |
|
| JBJ-08–178–01 / Dana-Farber Cancer Institute, Stanford University (0 Trials) |
|
| JBPOS0101 / Bio-Pharm Solutions (0 Trials) |
|
| JBPOS0755 / Bio-Pharm Solutions (0 Trials) |
|
| JCAR 023 / BMS (1 Trials) |
|
| JCAR014 / BMS (2 Trials) |
|
| JCAR018 / BMS, National Cancer Institute (2 Trials) |
|
| JCAR020 / BMS, Eureka Therap (1 Trials) |
|
| JCAR024 / BMS (2 Trials) |
|
| Jcovden (COVID-19 vaccine (Ad26.COV2-S [recombinant])) / J&J (0 Trials) |
|
| JCXH-211 IT / Immorna (0 Trials) |
|
| JCXH-212 / Immorna (0 Trials) |
|
| JD-2114 / Jenrin Discovery (0 Trials) |
|
| JD-4000 series / Jenrin Discovery (0 Trials) |
|
| JD010 / Beijing JD Biotech (0 Trials) |
|
| JD023 / Beijing JD Biotech (0 Trials) |
|
| JDS-MB-001 / Hisamitsu (0 Trials) |
|
| Jelmyto (mitomycin urothelial gel) / UroGen (0 Trials) |
|
| Jemdel (halobetasol propionate topical) / Bausch Health (0 Trials) |
|
| Jemperli (dostarlimab-gxly) / GSK (73 Trials) |
|
| Jesduvroq (daprodustat) / GSK, Kyowa Kirin (1 Trials) |
|
| Jeselhy (pimitespib) / Otsuka (0 Trials) |
|
| Jetrea (ocriplasmin) / Oxurion (0 Trials) |
|
| Jeuveau (prabotulinumtoxinA-xvfs) / AEON Biopharma (4 Trials) |
|
| JEZ567 / Novartis (0 Trials) |
|
| JGK-263 / Jeil (0 Trials) |
|
| JHL 1188 (trastuzumab biosimilar) / Eden Biologics (0 Trials) |
|
| JHL-1178 (ramucirumab biosimilar) / Eden Biologics (0 Trials) |
|
| JHL1101 (rituximab biosimilar) / Eden Biologics, Sanofi (0 Trials) |
|
| JHL1149 (bevacizumab biosimilar) / Eden Biologics (0 Trials) |
|
| JHL1199 (pertuzumab biosimilar) / Eden Biologics (0 Trials) |
|
| JHL1922 (dornase alfa biosimilar) / Eden Biologics (0 Trials) |
|
| JHU083 / Johns Hopkins University, AstraZeneca (0 Trials) |
|
| JHU395 / Dracen Pharma (0 Trials) |
|
| JI-101 / Jubilant Pharmova (0 Trials) |
|
| Jiayujian (infliximab biosimilar) / Walvax (0 Trials) |
|
| Jilifen (filgrastim biosimilar) / Hangzhou Jiuyuan Gene Engineering (0 Trials) |
|
| JIN-001 / J Ints Bio (0 Trials) |
|
| JIN-002 / J Ints Bio (0 Trials) |
|
| JIN-A01 / J Ints Bio (0 Trials) |
|
| JIN-A02 / J Ints Bio (0 Trials) |
|
| JIN-A03 / J Ints Bio (0 Trials) |
|
| Jingzhuda (entinostat) / EOC Pharma, EddingPharm (16 Trials) |
|
| Jinlitai (narlumosbart) / CSPC Pharma (0 Trials) |
|
| Jinlixi (xeligekimab) / Zhixiang (Shanghai) Pharma (0 Trials) |
|
| Jintropin (recombinant human growth hormone) / GeneScience (13 Trials) |
|
| Jinyouli (pegfilgrastim biosimilar) / CSPC Pharma (0 Trials) |
|
| Jisaixin (filgrastim biosimilar) / North China Pharma (0 Trials) |
|
| Jivadco (trastuzumab duocarmazine) / Byondis, Medac (1 Trials) |
|
| Jivi (damoctocog alfa pegol) / Bayer (6 Trials) |
|
| JJP-1008 / JJP Biologics (0 Trials) |
|
| JJP-1212 / JJP Biologics (0 Trials) |
|
| JK07 / Shenzhen Salubris (0 Trials) |
|
| JK500 cell injection / Escure Biotech (0 Trials) |
|
| JLP-1302 / Jeil (0 Trials) |
|
| JMB2002 / Jemincare (0 Trials) |
|
| JMBI-001 / Anticancer Biosci (0 Trials) |
|
| JMKX002992 / Roche (0 Trials) |
|
| JMKX1657 / Jemincare (0 Trials) |
|
| JMT601 / CSPC Pharma (0 Trials) |
|
| JN-210 / Jaan Biotherap (0 Trials) |
|
| JNJ 17305600 / J&J (0 Trials) |
|
| JNJ 26990990 / J&J (0 Trials) |
|
| JNJ 49095397 / J&J (0 Trials) |
|
| JNJ-0631 / J&J (0 Trials) |
|
| JNJ-0953 / J&J (0 Trials) |
|
| JNJ-1245 / J&J (0 Trials) |
|
| JNJ-1661010 / J&J (0 Trials) |
|
| JNJ-17166864 / J&J (0 Trials) |
|
| JNJ-18038683 / J&J (2 Trials) |
|
| JNJ-1887 / J&J (0 Trials) |
|
| JNJ-2056 / J&J (0 Trials) |
|
| JNJ-26366821 / J&J (0 Trials) |
|
| JNJ-26483327 / J&J (0 Trials) |
|
| JNJ-26489112 / J&J (1 Trials) |
|
| JNJ-27390467 / J&J (0 Trials) |
|
| JNJ-28312141 / J&J (0 Trials) |
|
| JNJ-28833155 / J&J (0 Trials) |
|
| JNJ-37822681 / J&J (0 Trials) |
|
| JNJ-38877605 / (0 Trials) |
|
| JNJ-39393406 / J&J (0 Trials) |
|
| JNJ-39758979 / J&J (0 Trials) |
|
| JNJ-40929837 / J&J (0 Trials) |
|
| JNJ-4178 / J&J (0 Trials) |
|
| JNJ-42165279 / J&J (0 Trials) |
|
| JNJ-42915925 / J&J (0 Trials) |
|
| JNJ-4681 / J&J (0 Trials) |
|
| JNJ-4703 / J&J (0 Trials) |
|
| JNJ-47910382 / J&J (0 Trials) |
|
| JNJ-48816274 / J&J (0 Trials) |
|
| JNJ-49122944 / J&J (0 Trials) |
|
| JNJ-5322 / J&J (0 Trials) |
|
| JNJ-54175446 / J&J (0 Trials) |
|
| JNJ-54257099 / Medivir, J&J (0 Trials) |
|
| JNJ-54271074 / J&J, Phenex Pharma (0 Trials) |
|
| JNJ-54728518 / J&J (0 Trials) |
|
| JNJ-5515 / J&J (0 Trials) |
|
| JNJ-55308942 / J&J (0 Trials) |
|
| JNJ-55920839 / J&J (0 Trials) |
|
| JNJ-5939 / J&J (0 Trials) |
|
| JNJ-61178104 / J&J (0 Trials) |
|
| JNJ-61393215 / J&J (0 Trials) |
|
| JNJ-61803534 / J&J (1 Trials) |
|
| JNJ-63682918 / J&J, Bavarian Nordic (0 Trials) |
|
| JNJ-63682931 / Bavarian Nordic, J&J (0 Trials) |
|
| JNJ-63709178 / J&J, Genmab (0 Trials) |
|
| JNJ-64158120 / J&J (0 Trials) |
|
| JNJ-64164711 / J&J (0 Trials) |
|
| JNJ-6420 / J&J (0 Trials) |
|
| JNJ-64213175 / J&J (0 Trials) |
|
| JNJ-64300535 / J&J (0 Trials) |
|
| JNJ-64417184 / J&J (0 Trials) |
|
| JNJ-64457744 / J&J (0 Trials) |
|
| JNJ-64530440 / J&J (0 Trials) |
|
| JNJ-64991524 / J&J (0 Trials) |
|
| JNJ-65195208 / J&J (0 Trials) |
|
| JNJ-66525433 / J&J (0 Trials) |
|
| JNJ-6665 / J&J (0 Trials) |
|
| JNJ-67571244 / J&J (0 Trials) |
|
| JNJ-67835989 / J&J (0 Trials) |
|
| JNJ-6892 / J&J, Epirus, Genefar (0 Trials) |
|
| JNJ-69095897 / J&J (0 Trials) |
|
| JNJ-74699157 / J&J (0 Trials) |
|
| JNJ-8114 / J&J (0 Trials) |
|
| JNJ-8343 / J&J (0 Trials) |
|
| JNJ-8543 / J&J (0 Trials) |
|
| JNJ-8902 / J&J, Genmab (0 Trials) |
|
| JNJ-9280 / J&J (0 Trials) |
|
| JNJ-9414 / J&J (0 Trials) |
|
| JNJ-95298177 / J&J (0 Trials) |
|
| JNJ-9530 / J&J (0 Trials) |
|
| JNK 359 / BMS (0 Trials) |
|
| JNK-IN-8 / Dana-Farber Cancer Institute, University of North Carolina-Chapel Hill (0 Trials) |
|
| JNX5050 / Junaxo (0 Trials) |
|
| Joenja (leniolisib) / Pharming Group (3 Trials) |
|
| Jogel Oral Gel (jojoba oil/lidocaine hydrochloride) / SEDICO (0 Trials) |
|
| Joicela (lumiracoxib) / Novartis (1 Trials) |
|
|